Taiwan Biomaterial Past Earnings Performance
Past criteria checks 0/6
Taiwan Biomaterial has been growing earnings at an average annual rate of 46.5%, while the Medical Equipment industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 53.4% per year.
Key information
46.5%
Earnings growth rate
47.4%
EPS growth rate
| Medical Equipment Industry Growth | 11.5% |
| Revenue growth rate | 53.4% |
| Return on equity | -1.6% |
| Net Margin | -13.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Taiwan Biomaterial makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 73 | -10 | 39 | 23 |
| 30 Sep 23 | 103 | 13 | 36 | 21 |
| 30 Jun 23 | 134 | 41 | 36 | 22 |
| 31 Mar 23 | 134 | 41 | 36 | 25 |
| 31 Dec 22 | 127 | 34 | 33 | 32 |
| 30 Sep 22 | 88 | 3 | 30 | 41 |
| 30 Jun 22 | 67 | -23 | 27 | 49 |
| 31 Mar 22 | 54 | -39 | 24 | 62 |
| 31 Dec 21 | 42 | -47 | 23 | 65 |
| 30 Sep 21 | 48 | -34 | 21 | 68 |
| 30 Jun 21 | 31 | -44 | 20 | 68 |
| 31 Mar 21 | 21 | -50 | 20 | 62 |
| 31 Dec 20 | 18 | -55 | 21 | 59 |
| 30 Sep 20 | 12 | -71 | 22 | 62 |
| 30 Jun 20 | 15 | -70 | 23 | 62 |
| 31 Mar 20 | 17 | -72 | 26 | 63 |
| 31 Dec 19 | 17 | -71 | 25 | 63 |
| 30 Sep 19 | 9 | -71 | 25 | 56 |
| 30 Jun 19 | 4 | -72 | 24 | 53 |
| 31 Mar 19 | 1 | -64 | 20 | 50 |
| 31 Dec 18 | 1 | -61 | 21 | 47 |
| 30 Sep 18 | 1 | -59 | 20 | 49 |
| 30 Jun 18 | 2 | -56 | 18 | 46 |
| 31 Mar 18 | 1 | -53 | 16 | 42 |
| 31 Dec 17 | 2 | -50 | 13 | 41 |
| 30 Sep 17 | 2 | -43 | 10 | 36 |
| 30 Jun 17 | 2 | -39 | 9 | 35 |
| 31 Mar 17 | 2 | -36 | 8 | 32 |
| 31 Dec 16 | 2 | -33 | 8 | 29 |
| 31 Dec 15 | 1 | -50 | 11 | 40 |
Quality Earnings: 6649 is currently unprofitable.
Growing Profit Margin: 6649 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6649 is unprofitable, but has reduced losses over the past 5 years at a rate of 46.5% per year.
Accelerating Growth: Unable to compare 6649's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6649 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: 6649 has a negative Return on Equity (-1.61%), as it is currently unprofitable.